US Patent 11124537 Inhibitors of glucocorticoid receptor

Patent 11124537 was granted and assigned to ORIC Pharmaceuticals on September, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

ORIC Pharmaceuticals

Current Assignee

ORIC Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

111245370

Patent Inventor Names

Yosup Rew0

Xiaohui Du0

Xuelei Yan0

Daqing Sun0

Haiying Zhou0

John Eksterowicz0

Julio C. Medina0

Lawrence R. McGee0

...

Date of Patent

September 21, 2021

Patent Application Number

201612220

Date Filed

December 22, 2016

Patent abstract

The present invention relates generally to compositions and methods for treating cancer and hypercortisolism. Provided herein are substituted steroidal derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of glucocorticoid receptors. Furthermore, the subject compounds and compositions are useful for the treatment of cancer and hypercortisolism.